OncLive

Education ▼

Register | Login

Conference Coverage

Attend An Event

State of the Science Summit

Regional Seminar Series

PER Conferences

Giants of Cancer Care

OncLive Community

Register today for a LIVE national broadcast on New Treatment Options for Rare Diseases in the Soft Tissue for March 5th and 6th!

SPECIALTY TOPICS

CURRENTLY VIEWING
All Specialties

Multiple Myeloma

Immuno-Oncology News

Gynecologic Oncology

Gastrointestinal Cancer

Colorectal Cancer

Prostate Cancer

Precision Medicine in Oncology^®

Neoadjuvant HER2+

OncLive TV: Celestia Higano, MD

<< Back to Our Featured Experts

Dr. Higano on the Effectiveness of PARP Inhibitors for Prostate Cancer

Dr. Higano on the Effectiveness of PARP Inhibitors for Prostate Cancer

Dr. Higano on Changes Being Made in the Field of Prostate Cancer

Dr. Higano on Changes Being Made in the Field of Prostate Cancer

Dr. Higano on Radium-223 for Prostate Cancer

Dr. Higano on Radium-223 for Prostate Cancer

Dr. Higano Discusses PARP Inhibitors in Prostate Cancer

Dr. Higano Discusses PARP Inhibitors in Prostate Cancer

Dr. Higano on Docetaxel for Hormone-Sensitive Prostate Cancer

Dr. Higano on Docetaxel for Hormone-Sensitive Prostate Cancer

Oncology Specialists

ABCDEFGHIJKLMNOPQRSTUVWXYZ

Ilaria Iacobucci, PhD

Gregory E. Idos, MD

James K. McCloskey II, MD

Charles A. (Trey) Leath III, MD

Charles A. Leath III, MD

David H. Ilson, MD, PhD

Raghava R. Induru, MD

Jeffrey R. Infante, MD

Brant Inman, MD

George N. Ioannou, MD

Syma Iqbal, MD

Luisa Iruela-Arispe, PhD

Melinda L. Irwin, PhD

Claudine Isaacs, MD

Tim Iveson, MD, FACP

Toshiaki Iwase, MD

Hiroji Iwata, MD, PhD

Puneeth Iyengar, MD

Gopa Iyer, MD

Renuka Iyer, MD

OncLive SAP

2020 Transplantation & Cellular Therapy Meetings News

Trending Now

Randall Ruminates on Challenges With Treating Sarcomas in AYA Patients

Breast Oncologists Aim to Address Key Unanswered Questions With Novel Research Efforts

FDA Accepts BLA for Subcutaneous Fixed-Dose Pertuzumab/Trastuzumab in HER2+ Breast Cancer

Long-Term Data Spark Investigation of Brentuximab Combos in Hodgkin Lymphoma Subgroups

Covering Every Angle of Oncology Practice. Click a cover below, to view more.

Publication Bottom Border

HER2+ Breast Cancer Advances

Rapid Reviews in Oncology®

Dermatologists in Cancer Care®

Priority Report

Milestones In Medicine

Pulmonologists in Cancer Care

Neuroendocrine Tumors

Rapid Reporter®

Non-Small Cell Lung Cancer Treatment

Urologists in Cancer Care

Oncology Business News

Contemporary Radiation Oncology

Oncology Nursing News

Oncology Fellows

Precision Medicine in Oncology

Invited Presentations

Oncology Treatment Pathways®

CURE Rare Cancers-Summer 2017 Issue

HEAL Summer 2017

Extraordinary Healers Vol. 11

Border Publication

External Resources

MJH Associates
American Journal of Managed Care
Cure
MD Magazine
Oncology Nursing News
Pharmacy Times
Physicians' Education Resource
Physician's Money Digest
Specialty Pharmacy Times
TargetedOnc

OncLive Resources

Articles
Blogs
Conference Coverage
OncLive TV
Peer Exchange
Publications
Specialties
Web Exclusives

About Us
Advertise
Advisory Board
Careers
Contact Us
Forgot Password
Press Releases
Privacy Policy
Terms & Conditions

iTunes

YouTube

Intellisphere, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-939-0221

Copyright OncLive 2006-2019
Intellisphere, LLC. All Rights Reserved.

x